A clinical trial is a research study that tests the current, most promising treatments for diseases. Most clinical trials in diseases, such as childhood cancer, sickle cell anemia or hemophilia, do not involve treatments which have never been tested before in children. Rather, they involve the testing of well-known medications given in new ways or in new combinations with other well-tested medications that are effective in that disease. The goal of a clinical trial is to identify treatment combinations that will provide the highest success rates or the best chance of a cure with the least amount of side effects.
Find a Clinical Trial
Visit our new online clinical trials database.
This tools allows you to easily search and view our open clinical trials. Here you will find a brief summary of each trial, objectives and eligibility criteria. |
|
Scientific discovery and advances in treatment have brought dramatic improvements in cure rates for many pediatric cancers during the last three years—from a 20 percent chance of survival before the 1960s to a more than 75 percent chance today. This remarkable progress is the result of clinical trials at the Aflac Cancer Center and other pediatric cancer and blood disorders hospitals worldwide. The Aflac Cancer Center currently participates in several hundred clinical trials and is a member of the Children’s Oncology Group—the primary governing body of all national pediatric and adolescent cancer research and clinical trials.